Stock Report

Morepen Laboratories Q3FY22 consolidated PAT falls to Rs. 21.52 crores

Posted On : 2022-02-08 12:04:30( TIMEZONE : IST )

Morepen Laboratories Limited has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 399.1902 crores during the period ended December 31, 2021 as compared to Rs. 398.1672 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 21.5212 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 37.3637 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 0.41 for the period ended December 31, 2021 as compared to Rs. 0.72 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 399.1902 crs	₹398.1672 crs	0.26%
Net Profit	₹21.5212 crs	₹37.3637 crs	-42.40%
EPS	₹0.41	₹0.72	-43.06%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 399.1902 crores during the period ended December 31, 2021 as compared to Rs.310.2633 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.21.5212 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.23.7934 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.0.41 for the period ended December 31, 2021 as compared to Rs.0.53 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 399.1902 crs	₹310.2633 crs	28.66%
Net Profit	₹21.5212 crs	₹23.7934 crs	-9.55%
EPS	₹0.41	₹0.53	-22.64%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.1185.6707 crores during the 9 Months period ended December 31, 2021 as compared to Rs.909.3630 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.89.3589 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.70.3295 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.1.72 for the 9 Months period ended December 31, 2021 as compared to Rs.1.56 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹1185.6707 crs	₹909.3630 crs	30.38%
Net Profit	₹89.3589 crs	₹70.3295 crs	27.06%
EPS	₹1.72	₹1.56	10.26%

Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 51.05 as compared to the previous close of Rs. 52.20. The total number of shares traded during the day was 322134 in over 3944 trades.

The stock hit an intraday high of Rs. 53.20 and intraday low of 50.75. The net turnover during the day was Rs. 16674076.00.